|Articles|November 19, 2014
Orphan Drug Specialty Firm Offers CRO Services
Cot? Orphan announced it will now provide CRO services that will help organizations navigate the clinical trials process
Advertisement
Coté Orphan, a regulatory affairs advisory firm specializing in orphan drugs, announced it will now provide CRO services that will help organizations navigate the clinical trials process through the lens of regulatory affairs. With the addition of the CRO services, Coté Orphan provides companies a complete and robust solution to those developing or seeking to develop orphan drugs.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Moving Beyond Historical Site Data to Real-Time Patient Insight
2
Why Trial Competition Is Undermining AI-Driven Gains
3
The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior License Execution Would Significantly Benefit Clinical Trial Set-Up
4
ACT Brief: Trial Competition Slows AI Gains, Rethinking Patient-Level Safety Decisions, and What Separates Real AI Platforms in Clinical Trials
5